MATTHEW REYNOLDS: Open Payments
NPI 1760855639 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,904 in 76 payments from 15 companies in 2025. Trend: 2023 $66,934 · 2024 $21,311 · 2025 $18,904
Speaker / faculty: $17,550Food & beverage: $1,113Travel & lodging: $241
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 26 | $18,017 |
| Novartis Pharmaceuticals Corporation | 10 | $181 |
| UCB, Inc. | 12 | $171 |
| PFIZER INC. | 9 | $161 |
| GENZYME CORPORATION | 4 | $93 |
| ABBVIE INC. | 2 | $39 |
| Janssen Biotech, Inc. | 2 | $37 |
| Galderma Laboratories, L.P. | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| Organon LLC | 2 | $30 |
Products named: EBGLYSS, Bimzelx, CIBINQO, COSENTYX, DUPIXENT, TALTZ, Rhapsido, SKYRIZI.
Industry payments across AR — which companies pay providers there.
